ALBANY, N.Y.--(BUSINESS WIRE)--AngioDynamics (NASDAQ:ANGO), a leading provider of innovative medical devices for the minimally-invasive treatment of cancer and peripheral vascular disease, today announced that it will report its fiscal 2011 first quarter financial results on Thursday, Oct. 7, 2010, after the close of the U.S. financial markets.
